Skip to main content
. 2023 Sep 6;16(9):1263. doi: 10.3390/ph16091263

Table 3.

Ligand structures and protein–ligand (P/L) RMSD at 0 and 200 ns.

Ligand Structure P/L RMSD (Å)
0 ns
P/L RMSD (Å)
200 ns
Methionine graphic file with name pharmaceuticals-16-01263-i001.jpg 2.14/1.50 3.74/6.80
MPH graphic file with name pharmaceuticals-16-01263-i002.jpg 1.46/1.18 4.00/6.67
MPJ graphic file with name pharmaceuticals-16-01263-i003.jpg 2.44/1.97 2.84/6.49
2FM graphic file with name pharmaceuticals-16-01263-i004.jpg 1.59/1.79 2.57/5.29
MF3 graphic file with name pharmaceuticals-16-01263-i005.jpg 1.36/2.72 4.08/3.17
MSP graphic file with name pharmaceuticals-16-01263-i006.jpg 1.15/2.52 2.65/7.56
Methionyl adenylate graphic file with name pharmaceuticals-16-01263-i007.jpg 1.92/3.63 2.59/4.36